Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

L 817818

Known as: L-817,818, L-817818, L817818 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The frequent overexpression of the somatostatin receptors sst2 and sst5 in neuroendocrine tumors provides the molecular basis for… Expand
2010
2010
In a recent study, we employed an in vivo model of retinal excitotoxicity to investigate the neuroprotective effect of… Expand
Highly Cited
2006
Highly Cited
2006
UNLABELLED The uptake of radiolabeled somatostatin analogs by tumor cells through receptor-mediated internalization is a critical… Expand
2005
2005
The secretion of GH by somatotropes is inhibited by somatostatin (SRIF) through five specific membrane receptors (SSTRs). SRIF… Expand
2003
2003
The mouse corticotroph tumour cell line AtT‐20 is a useful model to investigate the physiological role of native somatostatin… Expand
2003
2003
Of the five cloned somatostatin (SRIF: somatotropin release inhibitory factor) receptors (sst1–5), only sst2 and sst5 receptors… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
2002
2002
The diverse physiological actions of somatostatin are mediated by a family of G‐protein coupled receptors (SSTRs). Several… Expand
2001
2001
The effects of somatostatin (SRIF) are mediated through five distinct G-protein-coupled receptors (SSTR1-5). In the present study… Expand
Highly Cited
2000
Highly Cited
2000
Somatostatin (SST) potently inhibits insulin and glucagon release from pancreatic islets. Five distinct membrane receptors (SSTR1… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2000
Highly Cited
2000
Somatostatin (SST) potently inhibits insulin and glucagon release from pancreatic islets. Five distinct membrane receptors (SSTR1… Expand